| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |